DINGDANG HEALTH (09886) spent HK $114,000 on December 23 to buy back 101,500 shares.
Ding Dong Health (09886) announced that on December 23, 2025, the company spent 114,400 Hong Kong dollars to buy back 101,500 shares at a repurchase price of 1.11-1.13 Hong Kong dollars per share.
DINGDANG HEALTH (09886) announced that on December 23, 2025, the company spent 114,400 Hong Kong dollars to repurchase 101,500 shares, with a repurchase price of 1.11-1.13 Hong Kong dollars per share.
Related Articles
Maiwei Biological (688062.SH): The clinical trial application for 9MW1911 injection has been approved by the FDA.
On December 23rd, BEISEN HOLDING (09669) spent 1.3298 million Hong Kong dollars to repurchase 182,000 shares.
Goldwind Science & Technology's shareholder Harmony Health has reduced its holding in the company by approximately 31.89 million shares.
Maiwei Biological (688062.SH): The clinical trial application for 9MW1911 injection has been approved by the FDA.
On December 23rd, BEISEN HOLDING (09669) spent 1.3298 million Hong Kong dollars to repurchase 182,000 shares.
Goldwind Science & Technology's shareholder Harmony Health has reduced its holding in the company by approximately 31.89 million shares.
RECOMMEND
